Effects of R 56865 on Postischemic Ventricular Function in Isolated Rat Working Heart Preparations Obtained from Healthy, Diabetic and Hypertensive Animals

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1994 Jun 1

PMID 7969513

Citations 1

Authors

A J Pijl

M G Hendriks

K L Kam

M Paffendorf

P A van Zwieten

Affiliations

Soon will be listed here.

Abstract

The present study was undertaken to evaluate the effects of R 56865 (N-[1-[4-(4-fluorophenoxy)-butyl]-4-piperidinyl)- N-methyl-2-benzothiazolamine) (Fig. 1) on postischemic ventricular function, an inhibitor of the Na+/Ca2+ overload, in the working heart preparation of the rat. The hearts were paced at 5 Hz and perfused with Tyrode solution of 37 degrees C at a physiological pH. After 15 min of pretreatment with R 56865, low-flow ischemia (30 min) was induced by reducing the perfusion pressure from 51.5 mmHg to 11.0 mmHg and R 56865 was infused simultaneously. The hemodynamic effects of R 56865 were evaluated in the concentration range [10(-8)-3.10(-6) M]. The five parameters measured were: LVP (Left Ventricular Pressure), +dP/dtmax (maximal rate of pressure increase), AO (Aortic Output), CF (Coronary Flow) and CO (Cardiac Output). They were determined in the working heart mode after 15 min of equilibration and at the end of the experiment. From these data the recovery percentages were calculated. The recovery percentages for the LVP, +dP/dtmax, AO, CF and CO for the control hearts (3.3%, 0.0%, 7.9%, 10.4% and 8.5%, respectively) differed significantly from those at 10(-7) M (39.6%, 40.8%, 25.0%, 41.8% and 29.9% respectively). The recovery percentage were the highest at 10(-6) M (79.6%, 82.1%, 54.7%, 92.7% and 67.2%, respectively). The concentration of 10(-7) M was associated with a smaller reduction in LVP (12.9%) than at 10(-6) M (25.7%).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The negative inotropic and chronotropic effects of intravenous R 56865 during percutaneous transluminal coronary angioplasty.

Pijl A, Van Wezel H, Koolen J, Piek J, Koch K, Swaan A Br J Clin Pharmacol. 1995; 39(5):531-5.

PMID: 7669490 PMC: 1365061. DOI: 10.1111/j.1365-2125.1995.tb04491.x.

References

Himmel H, Wilhelm D, Ravens U . Effects of R56865 on membrane currents in isolated ventricular cardiomyocytes of the guinea-pig. Eur J Pharmacol. 1990; 187(2):235-40. DOI: 10.1016/0014-2999(90)90010-4. View

FLECKENSTEIN A . Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977; 17:149-66. DOI: 10.1146/annurev.pa.17.040177.001053. View

Frelin C, VIGNE P, Lazdunski M . The role of the Na+/H+ exchange system in the regulation of the internal pH in cultured cardiac cells. Eur J Biochem. 1985; 149(1):1-4. DOI: 10.1111/j.1432-1033.1985.tb08884.x. View

Finet M, Bravo G, GODFRAIND T . The protective action of R56865 against ouabain-induced intoxication in rat heart isolated atria and ventricles. Eur J Pharmacol. 1989; 164(3):555-63. DOI: 10.1016/0014-2999(89)90264-1. View

Carmeliet E, Tytgat J . Agonistic and antagonistic effect of R56865 on the Na+ channel in cardiac cells. Eur J Pharmacol. 1991; 196(1):53-60. DOI: 10.1016/0014-2999(91)90408-i. View

Daniels M, Ter Keurs H . Suppressive effects of R 56865 on triggered propagated contractions and triggered arrhythmias in rat cardiac trabeculae. J Cardiovasc Pharmacol. 1992; 20(2):187-96. DOI: 10.1097/00005344-199208000-00003. View

Opie L . Myocardial stunning: a role for calcium antagonists during reperfusion?. Cardiovasc Res. 1992; 26(1):20-4. DOI: 10.1093/cvr/26.1.20. View

Heusch G . Myocardial stunning: a role for calcium antagonists during ischaemia?. Cardiovasc Res. 1992; 26(1):14-9. DOI: 10.1093/cvr/26.1.14. View

Wilhelm D, Himmel H, Ravens U, Peters T . Characterization of the interaction of R 56865 with cardiac Na- and L-type Ca channels. Br J Pharmacol. 1991; 104(2):483-9. PMC: 1908563. DOI: 10.1111/j.1476-5381.1991.tb12455.x. View

10.

Muller J, Morrison J, Stone P, Rude R, Rosner B, Roberts R . Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984; 69(4):740-7. DOI: 10.1161/01.cir.69.4.740. View

11.

Lazdunski M, Frelin C, VIGNE P . The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985; 17(11):1029-42. DOI: 10.1016/s0022-2828(85)80119-x. View

12.

Sherman L, Liang C . Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial. Am J Cardiol. 1983; 51(5):706-11. DOI: 10.1016/s0002-9149(83)80119-2. View

13.

Pijl A, Pfaffendorf M, van Zwieten P . Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart. J Cardiovasc Pharmacol. 1993; 22(3):381-7. DOI: 10.1097/00005344-199309000-00006. View

14.

Opie L . Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action. Cardiovasc Drugs Ther. 1987; 1(4):411-30. DOI: 10.1007/BF02209083. View

15.

Vollmer B, Meuter C, Janssen P . R 56865 prevents electrical and mechanical signs of ouabain intoxication in guinea-pig papillary muscle. Eur J Pharmacol. 1987; 142(1):137-40. DOI: 10.1016/0014-2999(87)90663-7. View

16.

Tomlinson K, Gardiner S, Hebden R, Bennett T . Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev. 1992; 44(1):103-50. View

17.

Neely J, Liebermeister H, BATTERSBY E, Morgan H . Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967; 212(4):804-14. DOI: 10.1152/ajplegacy.1967.212.4.804. View

18.

Murphy E, Perlman M, London R, Steenbergen C . Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991; 68(5):1250-8. DOI: 10.1161/01.res.68.5.1250. View

19.

Verdonck F, Bielen F, Ver Donck L . Preferential block of the veratridine-induced, non-inactivating Na+ current by R56865 in single cardiac Purkinje cells. Eur J Pharmacol. 1991; 203(3):371-8. DOI: 10.1016/0014-2999(91)90893-u. View

20.

TEGTMEIER F, Wilhelm D, Frankow C, Thone F, Vandeplassche L, Peters T . Effects of R 56865 and phenytoin on mechanical, biochemical, and morphologic changes during ouabain intoxication in isolated perfused rabbit heart. J Cardiovasc Pharmacol. 1992; 20(3):421-8. DOI: 10.1097/00005344-199209000-00012. View